Abemaciclib metabolite M20
Abemaciclib metabolite M20 (CDK4/6-IN-4) is a pharmacologically active and selective CDK4/6 inhibitor derived from Abemaciclib. It is utilized in cancer research to investigate cell cycle inhibition in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
CAS Number
2138499-06-4
Product Name Alternative
Cyclin dependent kinase, CDK4, CDK, CDK4/6-IN-4, CDK6, Abemaciclib metabolite M 20, Abemaciclib metabolite M20, Abemaciclib metabolite M-20, Inhibitor, inhibit, LSN 3106726, LSN-3106726, LSN3106726
Field of Research
Cell Biology, Pharmacology & Drug Discovery
Purity
98.10% (May vary between batches)
Solubility
DMSO:4.5 mg/mL (8.61 mM)
Smiles
CCN1CCN (Cc2ccc (Nc3ncc (F) c (n3) -c3cc (F) c4nc (CO) n (C (C) C) c4c3) nc2) CC1
Molecular Formula
C27H32F2N8O
Molecular Weight
522.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
